
Alexander R. Menter, MD, oncologist, Kaiser Permanente, discusses the use of neoadjuvant immunotherapy in patients with early-stage non–small cell lung cancer (NSCLC).

Your AI-Trained Oncology Knowledge Connection!


Published: August 10th 2018 | Updated: